News Detail
New Delhi, 20 Feb 2025: The Materiovigilance Programme of India (MvPI), under the Indian Pharmacopoeia Commission (IPC), has released the draft in-vitro diagnostic medical device (IVD-MD) adverse event reporting form and has View Details
Source : Pharmabiz
Materiovigilance Programme of India
MvPI
Indian Pharmacopoeia Commission
IPC
in-vitro diagnostic medical device
IVD-MD
stakeholders
CDSCO
Drugs and Cosmetics Act
Medical Devices Rules
Post-market Surveillance
PMS
Related News
- Export NOCs, permission to manufacture and not approved by the importing country for combination of Tapentadol and Carisoprodol are revoked (22-02-2025)
- DCA Telangana cracks down on overpricing and misleading drug claims (22-02-2025)
- DCA busts unlicensed manufacturing drugs unit in Sangareddy (22-02-2025)
- A committee formed in Dehradun, to address the issue of companies producing counterfeit medications (22-02-2025)
- Govt Intensifies Inspections at Pharmaceutical Facilities to Ensure Quality (22-02-2025)
- BioAsia 2025 to host Global Healthcare Leaders to drive transformative innovation (22-02-2025)
- Bihar Takes Firm Stance Against Counterfeit Medicines, Health Secretary Issues Strong Directives (22-02-2025)
- Bombay HC Quashes Income Tax Reassessment Notice Against Lupin Ltd For AY 2016-17 (22-02-2025)
- Govt extends Rajeev Singh Raghuvanshi's tenure as DCGI by one year (22-02-2025)
- CrisprBits develops PathCrisp for detection of AMR (22-02-2025)